ICON expects market conditions to remain similar through year-end, assuming persistent cancellation rates and mixed timing on biotech conversions. The company raised its full year revenue guidance to ...
Full-year revenue guidance was updated to a new range of $7.85 billion at the low end and $8.15 billion at the high end, "increasing the midpoint to $8 billion." The full-year adjusted earnings per ...
Earnings Call Insights: ICON Public Limited Company (NASDAQ:ICLR) Q4 2024 CEO Steve Cutler introduced Barry Balfe as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results